Association of donor/recipient sex and relapse is not solely explained by GVHD
Donor/recipient sex . | Adjusted hazard ratio* . | 95% CI . | Pr . |
|---|---|---|---|
| Female/male | 1 | NA | NA |
| Male/female | 1.20 | 0.96-1.50 | .10 |
| Female/female | 1.27 | 1.02-1.58 | .03 |
| Male/male | 1.43 | 1.18-1.73 | .0003 |
Donor/recipient sex . | Adjusted hazard ratio* . | 95% CI . | Pr . |
|---|---|---|---|
| Female/male | 1 | NA | NA |
| Male/female | 1.20 | 0.96-1.50 | .10 |
| Female/female | 1.27 | 1.02-1.58 | .03 |
| Male/male | 1.43 | 1.18-1.73 | .0003 |
NA indicates not applicable.
Adjusted for patient and donor age, GVHD prophylaxis, disease status, conditioning regimen, patient/donor CMV serostatus, and acute and chronic GVHD.